Bioartificial livers in vitro and in vivo: tailoring biocomponents to the expanding variety of applications. - Wikidata - wikimedia - TriplyDB

Bioartificial livers in vitro and in vivo: tailoring biocomponents to the expanding variety of applications.

Bioartificial livers in vitro and in vivo: tailoring biocomponents to the expanding variety of applications.

http://www.wikidata.org/entity/Q38264625

about

Two Effective Routes for Removing Lineage Restriction Roadblocks: From Somatic Cells to Hepatocytes Selecting Cells for Bioartificial Liver Devices and the Importance of a 3D Culture Environment: A Functional Comparison between the HepaRG and C3A Cell Lines Zebularine upregulates expression of CYP genes through inhibition of DNMT1 and PKR in HepG2 cells.Extracorporeal liver support devices for listed patients.Cell therapy in chronic liver disease.Challenges on the road to a multicellular bioartificial liver.Oxygen drives hepatocyte differentiation and phenotype stability in liver cell lines.Transcription Factors and Medium Suitable for Initiating the Differentiation of Human-Induced Pluripotent Stem Cells to the Hepatocyte Lineage.A practice-changing culture method relying on shaking substantially increases mitochondrial energy metabolism and functionality of human liver cell lines.Reversibly immortalized hepatic progenitor cell line containing double suicide genes

P2860

Q26784188-F742E461-283A-4497-AC8A-301D1DD4F973 Q37148553-099CAF85-AC6D-4849-9C08-431A110E53B0 Q37598574-71984149-ECC9-495F-8892-CCBC15D84682 Q38702799-FE8C54AE-EFF5-4D7D-855B-AF97FBA20CCA Q38763661-2E3E3808-D091-40A2-BD35-A35AAC28895F Q39036360-1EC5A582-D7C7-49EB-9F14-8FC0BC3A0B06 Q48108728-64E6F6F3-C3F8-4604-9C46-9989C7BE194B Q51559790-95441615-DB69-42C2-B3A5-45F6C71CA6CC Q55249382-4A5511AA-CF8A-416B-840B-BAFAB5F126EB Q58802961-F908569F-D11B-4362-AD24-143CEA6A8C79

P2860

Bioartificial livers in vitro and in vivo: tailoring biocomponents to the expanding variety of applications.

http://www.wikidata.org/entity/Q38264625

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Bioartificial livers in vitro ...... nding variety of applications.

@en

type

label

Bioartificial livers in vitro ...... nding variety of applications.

@en

prefLabel

Bioartificial livers in vitro ...... nding variety of applications.

@en

P1433

Q38264625-5D9BCDF4-0F99-4362-8D13-BC593B374292

P1476

Q38264625-8D32956C-4847-452C-84C4-F24F749FCEE5

P2093

Q38264625-17BE8538-5CCC-46E5-8BF6-BDC2C474B251

Q38264625-2E15904E-6BA9-46FC-AD65-280F5B5A3B7A

Q38264625-B3E4AD73-1D87-4707-A557-429C6EE07325

Q38264625-D6B8D62C-C194-4A4B-847A-C1711D94A777

Q38264625-F4710667-63CC-4CFC-8BDE-0F9B189EACE2

P2860

Q38264625-00065A07-3DCF-431A-A925-5610F2C4469A

Q38264625-05418BAD-F129-41D7-A392-B6F1429F7CEF

Q38264625-057AC510-8803-4E7D-AC25-F66902ECD984

Q38264625-0B4617D2-393B-4ECA-B0EA-A32060809071

Q38264625-0D76E04E-85C0-451E-92F1-0A6B4695D05D

Q38264625-0DE7C19F-B6C3-4413-8ED8-0E33B762F846

Q38264625-10F63AD5-9FB5-41D6-80A7-0FFD61263B63

Q38264625-11FD3A61-3445-4D60-A868-7C9B0E57C006

Q38264625-1384F297-A409-484B-BFBB-3CEB62BE6DE3

Q38264625-14CEBF78-156F-42FE-8C8D-75D8E2A6ABF3

P304

Q38264625-CDB954FD-89D5-4730-8106-408042F5DDC2

P31

Q38264625-9E5079CB-B184-4723-AC0F-7568923624B6

P356

Q38264625-030F0085-4B59-448A-9BF3-3B7839AE694C

P407

Q38264625-5DC03AC6-2B1B-45D3-8060-3CA18D52DD02

P433

Q38264625-BA17ACD9-0336-4F16-B0C7-2BC7C9D2A18C

P478

Q38264625-7FCAA97D-98BB-40EF-B790-B358270C186C

P50

Q38264625-9DD98226-578D-46BF-98BB-8435083F1D2D

P577

Q38264625-2645B4CA-5C9A-4667-A666-5350467F2698

P698

Q38264625-6C735CD6-301F-430F-8AB9-F57DCABC9FD1

P356

14712598.2014.950651

P1433

Expert Opinion on Biological Therapy

P1476

Bioartificial livers in vitro ...... nding variety of applications.

@en

P2093

Adriaan Siliakus

http://www.w3.org/2001/XMLSchema#string

Martien van Wenum

http://www.w3.org/2001/XMLSchema#string

Robert Afm Chamuleau

http://www.w3.org/2001/XMLSchema#string

Ruurdtje Hoekstra

http://www.w3.org/2001/XMLSchema#string

Thomas M van Gulik

http://www.w3.org/2001/XMLSchema#string

P2860

Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet?

Evaluation of encapsulated liver cell spheroids in a fluidised-bed bioartificial liver for treatment of ischaemic acute liver failure in pigs in a translational setting

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Preparation of isolated rat liver cells

Drug interaction studies: study design, data analysis, and implications for dosing and labeling.

Auxiliary partial orthotopic versus standard orthotopic whole liver transplantation for acute liver failure: a reappraisal from a single center by a case-control study.

Genomics and proteomics analysis of cultured primary rat hepatocytes.

Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure

Cytochrome p450 and chemical toxicology.

Biochemical and molecular characterization of hepatocyte-like cells derived from human bone marrow mesenchymal stem cells on a novel three-dimensional biocompatible nanofibrous scaffold.

P304

1745-1760

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2014.950651

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25366164

http://www.w3.org/2001/XMLSchema#string